tailieunhanh - báo cáo hóa học:" Sigma-2 receptor ligands potentiate conventional chemotherapies and improve survival in models of pancreatic adenocarcinoma"

Tuyển tập các báo cáo nghiên cứu về hóa học được đăng trên tạp chí sinh học quốc tế đề tài : Sigma-2 receptor ligands potentiate conventional chemotherapies and improve survival in models of pancreatic adenocarcinoma | Journal of Translational Medicine BioMed Central Research Sigma-2 receptor ligands potentiate conventional chemotherapies and improve survival in models of pancreatic adenocarcinoma Hiroyuki Kashiwagi1 Jonathan E McDunn2 Peter O Simon Jr1 Peter S Goedegebuure1 3 Suwanna Vangveravong4 Katherine Chang2 Richard S Hotchkiss2 Robert H Mach4 and William G Hawkins 1 3 Open Access Address Department of Surgery Washington University School of Medicine 660 S. Euclid Avenue Campus Box 8109 St. Louis MO 63110 USA 2Department of Anesthesiology Washington University School of Medicine 660 S. Euclid Avenue St. Louis MO 63110 USA 3Alvin J. Siteman Cancer Center Washington University School of Medicine 660 S. Euclid Avenue Campus Box 8109 St. Louis MO 63110 USA and 4Department of Radiology Washington University School of Medicine 660 S. Euclid Avenue St. Louis MO 63110 USA Email Hiroyuki Kashiwagi - hiroyukiwagi1967@ Jonathan E McDunn - mcdunnj@ Peter O Simon - simonpo@ Peter S Goedegebuure - goedegep@ Suwanna Vangveravong - vangveravongs@ Katherine Chang - changk@ Richard S Hotchkiss - hotchkir@ Robert H Mach - rhmach@ William G Hawkins - hawkinsw@ Corresponding author Published 26 March 2009 Received 14 November 2008 _ . -mno .- nom z-rn roi 1 IZ Accepted 26 March 2009 Journal of Translational Medicine 2009 7 24 doi l479-5876-7-24 This article is available from http content 7 1 24 2009 Kashiwagi et al licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License http licenses by which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Abstract Background We have previously reported that the sigma-2 receptor is highly expressed in pancreas cancer. .